Synthesis of a novel universal opioid receptor agonist with the 1,3,5-trioxazatriquinane skeleton and its pharmacologies

Bioorg Med Chem Lett. 2014 Oct 15;24(20):4895-8. doi: 10.1016/j.bmcl.2014.08.012. Epub 2014 Aug 12.

Abstract

We designed and synthesized of 1,3,5-trioxazatriquinanes with o- or p-hydroxyphenyl rings as analogs of the κ opioid receptor agonist SYK-146 with m-hydroxyphenyl groups. Although almost all tested compounds did not bind to the opioid receptors, only 17b (SYK-524) with two o-hydroxyphenyl rings showed moderate or potent binding affinities and exhibited agonistic activities for the three opioid receptor types. Because the basicity of the nitrogen atom in the 1,3,5-trioxazatriquinane structure was predicted to be very low due to the electron withdrawing effect of the three oxygen atoms, SYK-524 was a novel non-morphinan and nonpeptidic opioid universal agonist lacking a basic nitrogen atom.

Keywords: Opioid; Phenethylamine; Universal agonist.

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Guinea Pigs
  • Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
  • Heterocyclic Compounds, 4 or More Rings / chemistry
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Humans
  • Mice
  • Molecular Conformation
  • Receptors, Opioid, kappa / agonists*
  • Structure-Activity Relationship

Substances

  • 1,3,5-trioxazatriquinane
  • Heterocyclic Compounds, 4 or More Rings
  • Receptors, Opioid, kappa